
Dacoplice 45mg Tablet
Marketer
Pfizer Ltd
Salt Composition
Dacomitinib (45mg)
Overview Dacoplice 45mg Tablet
This medication, Dacoplice 45mg tablets, treats non-small cell lung cancer by inhibiting cancer cell proliferation. Administer this medication with or without food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, based on your condition and may adjust over time. Strict adherence to the prescribed regimen is crucial, as deviations can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under your doctor's instruction. Common side effects include diarrhea, rash, mouth sores, nail inflammation, reduced appetite, dry skin, weight loss, hair loss, cough, and itching. Seek immediate medical attention for serious side effects such as fatigue, severe itching, jaundice, chest pain, or irregular heartbeat. Pre- and post-treatment blood tests may monitor liver and blood sugar levels. Inform your doctor about all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners during treatment. A patient support program, managed by Tata 1mg, is available in India; contact your physician or call (1800-102-1618) for details.
Uses of Dacoplice 45mg Tablet
Managing Non-small Cell Lung Carcinoma
Major Benefits of Dacoplice 45mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 45mg Dacoplice tablet whole; do not break, crush, or chew it. While you can take it with or without food, consistent timing is recommended.
Common Side effects of Dacoplice 45mg Tablet:
- Constipation
- Stomatitis (Inflammation of the mouth)
- Rash
- Diarrhea
- Weight loss
- Cough
- Low albumin level in blood
- Paronychia
- Increased glucose level in blood
- Decreased calcium level in blood
- Increased liver enzymes
- Dry skin
- Decreased appetite
- Lymphopenia
How to use Dacoplice 45mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the 45mg Dacoplice tablet whole; avoid crushing, chewing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended for optimal results.
How Dacoplice 45mg Tablet works:
Dacoplice 45mg tablets target the human epidermal growth factor receptor (HER) protein, a key driver of accelerated cancer cell growth and metastasis. This action helps to control cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dacoplice 45mg Tablet may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Dacoplice 45mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Dacoplice 45mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Dacoplice 45mg Tablet's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate a dosage modification for Dacoplice 45mg tablets, which are considered safe for use in such patients.
LiverSAFE IF PRESCRIBED
Patients with hepatic impairment may safely use Dacoplice 45mg tablets without requiring a dosage modification.
What if you forget to take Dacoplice 45mg Tablet :
NA
Facts to Know About Dacoplice 45mg Tablet
Label | Value |
---|---|
Chemical Type | Quinazoline derivative |
Developing Habits | No. |
Treatment Category | Cancer Medications |